H. Williams

Improving access and efficiency of ischemic stroke treatment across four Canadian provinces using a stepped wedge trial: Methodology

K. Mrklas, B. Menon, J. Goldstein, 2022, Frontiers in Stroke.

AcT Trial: Protocol for a Pragmatic Registry‐Linked Randomized Clinical Trial

Thalia Shoshana Field, R. Swartz, T. Sajobi, 2022, Stroke: Vascular and Interventional Neurology.

Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial

Alexander M. Fraser, Thalia Shoshana Field, Susan E. Alcock, 2022, The Lancet.

Genetic testing for amyotrophic lateral sclerosis in Canada – an assessment of current practices

A. Izenberg, S. Tremblay, C. O'Connell, 2021, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Effect of Time to Thrombolysis on Clinical Outcomes in Patients with Acute Ischemic Stroke Treated with Tenecteplase Compared to Alteplase: Analysis from the AcT Randomized Controlled Trial

Thalia Shoshana Field, A. Pikula, G. Gubitz, 2023, medRxiv.

Alteplase Compared to Tenecteplase in patients with Acute Ischemic Stroke (AcT) Trial: Protocol for a Pragmatic Registry linked Randomized Clinical Trial

Thalia Shoshana Field, R. Swartz, T. Sajobi, 2022, Stroke: Vascular and Interventional Neurology.

Safety and Efficacy of Tenecteplase Compared With Alteplase in Patients With Large Vessel Occlusion Stroke: A Prespecified Secondary Analysis of the ACT Randomized Clinical Trial.

Thalia Shoshana Field, R. Swartz, T. Sajobi, 2023, JAMA neurology.

Quality of Life After Intravenous Thrombolysis for Acute Ischemic Stroke: Results From the AcT Randomized Controlled Trial

M. Kate, L. Gioia, T. Sajobi, 2024, Stroke.